Avalon Globocare shares surge 18.37% premarket as shareholders approve capital measures including common share issuance.

Avalon GloboCare surged 18.37% in premarket trading following the announcement that shareholders approved a series of financing-related measures on March 30, 2026. The approval included the issuance of common shares upon conversion of previously undisclosed instruments, signaling a positive step toward strengthening the company’s capital structure and potentially supporting future growth initiatives.